![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Phase 2 Randomized, Double-Blind Placebo-Controlled Study of Nitazoxanide with Peginterferon Alfa-2a and Ribavirin in Nonresponders with Chronic Hepatitis C Genotype 1: Final Report
|
|
|
Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria
M.L. Shiffman A Ahmed, I.M. Jacobson, R.E, Pruitt, E.B. Keefe, USA
![](../images/041910/041910-10/image002.gif)
![](../images/041910/041910-10/image004.gif)
![](../images/041910/041910-10/image006.gif)
![](../images/041910/041910-10/image008.gif)
![](../images/041910/041910-10/image010.gif)
![](../images/041910/041910-10/image012.gif)
![](../images/041910/041910-10/image014.gif)
![](../images/041910/041910-10/image016.gif)
![](../images/041910/041910-10/image018.gif)
![](../images/041910/041910-10/image020.gif)
![](../images/041910/041910-10/image022.gif)
![](../images/041910/041910-10/image024.gif)
![](../images/041910/041910-10/image026.gif)
![](../images/041910/041910-10/image028.gif)
![](../images/041910/041910-10/image030.gif)
![](../images/041910/041910-10/image032.gif)
![](../images/041910/041910-10/image034.gif)
![](../images/041910/041910-10/image036.gif)
![](../images/041910/041910-10/image038.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|